Canada Health Canada to increase legal access to psychedelics for therapy Psychedelics firm Numinus says amendments made to the country's Special Access Programme come into effect in January Natalia Buendia CalvilloDecember 28, 2021
Business Numinus ends fiscal year with revenue up 72% to $1.5M, losses of $19M The psychedelics firm has been aggressively expanding lab space while pushing ahead with clinical trials Natalia Buendia CalvilloDecember 10, 2021
Business Field Trip Health opens clinic in Vancouver: Q&A with founder Ronan Levy The new facility will feature the firm's ketamine-assisted therapy program, as well as a range of health and lifestyle services Nick LabaDecember 8, 2021
Business Numinus develops in-house tests to detect compounds in psychedelic mushrooms The methods will be available as part of third-party client services Nick LabaNovember 29, 2021
Psychedelics Psychedelic microdosers report less anxiety and depression: study Some are criticizing researcher Stamets for trying to capitalize on the phenomenon of 'stacking,' where psychedelics are paired with health supplements Natalia Buendia CalvilloNovember 22, 2021
Cannabis Consuming cannabis while on psychedelics makes the experience stronger, researchers say Cannabis and 'classical' psychedelics could act on similar receptors Natalia Buendia CalvilloNovember 4, 2021
International UK Prime Minister to consider reducing legal barriers to psilocybin research Conservative MP and drug policy reform chair Crispin Blunt suggests reclassifying the substance to a less severe category of the country's drug law Natalia Buendia CalvilloOctober 25, 2021
Health and Safety Can psilocybin help smokers quit? Johns Hopkins to study impact with NIH grant It’s the first federal grant to be awarded for psychedelic treatment research in 50 years Kathryn TindaleOctober 19, 2021
Canada Health Canada says patients should access medical psilocybin via clinical trials When asked why patient requests for legal psilocybin are being denied or delayed, the agency said studies are the best route for access Natalia Buendia CalvilloAugust 11, 2021
Canada Advocacy group drafts medical psilocybin framework for regulated access TheraPsil's CEO expects change for psilocybin to come in a matter of months because of the work done for cannabis Kathryn TindaleAugust 4, 2021